11-36575763-A-G

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BS2_SupportingBA1

This summary comes from the ClinGen Evidence Repository: The NM_000448.3:c.2459A>G variant in RAG1 is a missense variant predicted to cause the substitution of Lysine by Arginine at amino acid 820 (p.Lys820Arg). The filtering allele frequency (the lower threshold of the 95% CI of 26338/44862) of the c.2459A>G variant in RAG1 is 0.5818 for East Asian chromosomes by gnomAD v.4, which is higher than the ClinGen SCID VCEP threshold (>0.00872) for BA1, and therefore meets this criterion (BA1). Additionally, 22786 homozygous adults are reported on gnomAD v.4, BS2_Supporting is Met.In summary, this variant meets the criteria to be classified as Benign for autosomal recessive SCID. ACMG/AMP criteria applied, as specified by the ClinGen SCID-VCEP: BA1 and BS2_Supporting. (VCEP specifications version 1). LINK:https://erepo.genome.network/evrepo/ui/classification/CA5950267/MONDO:0000572/123

Frequency

Genomes: 𝑓 0.14 ( 2323 hom., cov: 33)
Exomes 𝑓: 0.14 ( 20463 hom. )

Consequence

RAG1
NM_000448.3 missense

Scores

5
13

Clinical Significance

Benign reviewed by expert panel B:13

Conservation

PhyloP100: 2.86
Variant links:
Genes affected
RAG1 (HGNC:9831): (recombination activating 1) The protein encoded by this gene is involved in activation of immunoglobulin V-D-J recombination. The encoded protein is involved in recognition of the DNA substrate, but stable binding and cleavage activity also requires RAG2. Defects in this gene can be the cause of several diseases. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BS2
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
RAG1NM_000448.3 linkuse as main transcriptc.2459A>G p.Lys820Arg missense_variant 2/2 ENST00000299440.6 NP_000439.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
RAG1ENST00000299440.6 linkuse as main transcriptc.2459A>G p.Lys820Arg missense_variant 2/21 NM_000448.3 ENSP00000299440.5 P15918-1

Frequencies

GnomAD3 genomes
AF:
0.141
AC:
21427
AN:
152140
Hom.:
2319
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0997
Gnomad AMI
AF:
0.249
Gnomad AMR
AF:
0.235
Gnomad ASJ
AF:
0.163
Gnomad EAS
AF:
0.579
Gnomad SAS
AF:
0.279
Gnomad FIN
AF:
0.0865
Gnomad MID
AF:
0.225
Gnomad NFE
AF:
0.107
Gnomad OTH
AF:
0.149
GnomAD3 exomes
AF:
0.195
AC:
48854
AN:
250564
Hom.:
7531
AF XY:
0.190
AC XY:
25783
AN XY:
135432
show subpopulations
Gnomad AFR exome
AF:
0.0982
Gnomad AMR exome
AF:
0.345
Gnomad ASJ exome
AF:
0.166
Gnomad EAS exome
AF:
0.590
Gnomad SAS exome
AF:
0.261
Gnomad FIN exome
AF:
0.0839
Gnomad NFE exome
AF:
0.106
Gnomad OTH exome
AF:
0.170
GnomAD4 exome
AF:
0.136
AC:
198634
AN:
1461858
Hom.:
20463
Cov.:
36
AF XY:
0.139
AC XY:
101107
AN XY:
727234
show subpopulations
Gnomad4 AFR exome
AF:
0.0966
Gnomad4 AMR exome
AF:
0.334
Gnomad4 ASJ exome
AF:
0.163
Gnomad4 EAS exome
AF:
0.588
Gnomad4 SAS exome
AF:
0.252
Gnomad4 FIN exome
AF:
0.0879
Gnomad4 NFE exome
AF:
0.104
Gnomad4 OTH exome
AF:
0.158
GnomAD4 genome
AF:
0.141
AC:
21442
AN:
152260
Hom.:
2323
Cov.:
33
AF XY:
0.147
AC XY:
10975
AN XY:
74464
show subpopulations
Gnomad4 AFR
AF:
0.0995
Gnomad4 AMR
AF:
0.236
Gnomad4 ASJ
AF:
0.163
Gnomad4 EAS
AF:
0.579
Gnomad4 SAS
AF:
0.278
Gnomad4 FIN
AF:
0.0865
Gnomad4 NFE
AF:
0.107
Gnomad4 OTH
AF:
0.153
Alfa
AF:
0.120
Hom.:
3507
Bravo
AF:
0.152
TwinsUK
AF:
0.112
AC:
414
ALSPAC
AF:
0.104
AC:
399
ESP6500AA
AF:
0.108
AC:
474
ESP6500EA
AF:
0.114
AC:
981
ExAC
AF:
0.186
AC:
22633
Asia WGS
AF:
0.371
AC:
1287
AN:
3478
EpiCase
AF:
0.111
EpiControl
AF:
0.113

ClinVar

Significance: Benign
Submissions summary: Benign:13
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanJan 24, 2024This variant is classified as Benign based on local population frequency. This variant was detected in 48% of patients studied by a panel of primary immunodeficiencies. Number of patients: 42. Only high quality variants are reported. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 28, 2016Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - papers in HGMD do not provide evidence of disease association -
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaMar 06, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabNov 07, 2021- -
Histiocytic medullary reticulosis Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaMar 06, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabNov 07, 2021- -
not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015This variant is associated with the following publications: (PMID: 16857995, 24290284, 22424479, 21625022) -
Combined immunodeficiency with skin granulomas Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabNov 07, 2021- -
Recombinase activating gene 1 deficiency Benign:1
Benign, reviewed by expert panelcurationClinGen Severe Combined Immunodeficiency Variant Curation Expert Panel, ClinGenJan 23, 2024The NM_000448.3:c.2459A>G variant in RAG1 is a missense variant predicted to cause the substitution of Lysine by Arginine at amino acid 820 (p.Lys820Arg). The filtering allele frequency (the lower threshold of the 95% CI of 26338/44862) of the c.2459A>G variant in RAG1 is 0.5818 for East Asian chromosomes by gnomAD v.4, which is higher than the ClinGen SCID VCEP threshold (>0.00872) for BA1, and therefore meets this criterion (BA1). Additionally, 22786 homozygous adults are reported on gnomAD v.4, BS2_Supporting is Met. In summary, this variant meets the criteria to be classified as Benign for autosomal recessive SCID. ACMG/AMP criteria applied, as specified by the ClinGen SCID-VCEP: BA1 and BS2_Supporting. (VCEP specifications version 1). -
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;C2673536:Combined immunodeficiency with skin granulomas Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Immunodeficiency 104 Benign:1
Benign, criteria provided, single submitterclinical testingGreenArray Genomic Research & Solutions of Accurate Diagnostic Private Limited-The variant is predicted to be benign by PolyPhen2 and the residue is conserved across species. The amino acid change p.Lys820Arg in RAG1 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
16
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.60
D
Eigen
Benign
-0.27
Eigen_PC
Benign
-0.18
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Uncertain
0.88
D
MetaRNN
Benign
0.000045
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
1.7
L
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.20
Sift
Uncertain
0.0010
D
Sift4G
Benign
0.099
T
Polyphen
0.0010
B
Vest4
0.019
MPC
0.15
ClinPred
0.034
T
GERP RS
2.6
Varity_R
0.14
gMVP
0.46

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2227973; hg19: chr11-36597313; COSMIC: COSV55024177; API